| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.32(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Grossman Jerrold B |
Director |
– • – |
2016-05-03 |
4 |
B |
$6.50 |
$297,499 |
I/I |
45,769 |
106,327 |
2.1 |
- |
|
| Lenz Brian |
Chief Financial Officer |
• – – |
2016-05-03 |
4 |
B |
$6.50 |
$16,250 |
D/D |
2,500 |
8,500 |
2.74 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2016-05-03 |
4 |
B |
$6.50 |
$1,300,000 |
I/I |
200,000 |
843,668 |
2.66 |
- |
|
| Mond James |
CSO/CMO |
• – – |
2016-05-03 |
4 |
B |
$6.50 |
$5,005 |
D/D |
770 |
3,389 |
2.74 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-18 |
4 |
B |
$8.47 |
$54,224 |
I/I |
6,400 |
643,668 |
2.66 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2015-12-18 |
4 |
B |
$8.48 |
$33,918 |
D/D |
4,000 |
60,558 |
2.39 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-08 |
4 |
B |
$8.99 |
$2,697 |
D/D |
300 |
637,268 |
2.73 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2015-12-07 |
4 |
B |
$9.01 |
$4,503 |
D/D |
500 |
56,558 |
2.31 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-07 |
4 |
B |
$9.01 |
$1,804 |
D/D |
200 |
636,968 |
2.73 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2015-12-02 |
4 |
B |
$9.16 |
$54,961 |
D/D |
6,000 |
56,058 |
2.39 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-02 |
4 |
B |
$9.13 |
$6,848 |
D/D |
750 |
636,768 |
2.81 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-02 |
4 |
B |
$9.15 |
$13,736 |
I/I |
1,500 |
636,018 |
2.58 |
- |
|
| Lenz Brian |
Chief Financial Officer |
• – – |
2015-12-02 |
4 |
B |
$9.14 |
$9,151 |
D/D |
1,000 |
6,000 |
2.74 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-12-01 |
4 |
B |
$9.17 |
$16,513 |
I/I |
1,800 |
634,518 |
2.58 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-11-25 |
4 |
B |
$9.18 |
$16,529 |
I/I |
1,800 |
632,718 |
2.58 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-11-20 |
4 |
B |
$9.26 |
$23,146 |
I/I |
2,500 |
630,918 |
2.58 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-11-20 |
4 |
B |
$9.12 |
$3,293 |
D/D |
361 |
628,418 |
2.73 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-11-19 |
4 |
B |
$9.13 |
$9,134 |
I/I |
1,000 |
628,057 |
2.58 |
- |
|
| Lenz Brian |
Chief Financial Officer |
• – – |
2015-03-19 |
4 |
B |
$8.82 |
$6,714 |
D/D |
750 |
5,000 |
2.74 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-03-19 |
4 |
B |
$8.50 |
$16,997 |
I/I |
2,000 |
627,057 |
2.58 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2015-03-17 |
4 |
B |
$8.01 |
$4,004 |
I/I |
500 |
578,074 |
2.1 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2015-03-17 |
4 |
B |
$7.98 |
$43,880 |
I/I |
5,500 |
625,057 |
2.66 |
- |
|
| Guiheen Lawrence P. |
Director |
– • – |
2015-03-16 |
4 |
B |
$7.96 |
$7,959 |
D/D |
1,000 |
6,000 |
2.39 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2015-03-16 |
4 |
B |
$8.00 |
$9,597 |
I/I |
1,200 |
577,574 |
2.1 |
- |
|
| Mond James |
CSO/CMO |
• – – |
2015-03-16 |
4 |
B |
$8.02 |
$10,025 |
D/D |
1,250 |
2,565 |
2.74 |
- |
|
222 Records found
|
|
Page 7 of 9 |
|
|
0.07 (1.05%) 
